Ovid Therapeutics (OVID) Competitor Comparison
We are evaluating the key criteria listed to compare Ovid Therapeutics (OVID) against its competitors in the Biotechnology industry.
Market Capitalization
212 / 368Gross Profits
122 / 278Total Revenue
265 / 300EBITDA
141 / 337Free Cashflow
156 / 352Quick Ratio
78 / 357Earnings per Share
96 / 359Dividend yield
0 / 6Total Cash
226 / 358Performance 3 years
125 / 368Performance 5 years
66 / 368Performance 10 years
205 / 368Linearity 3 years
54 / 368Linearity 5 years
112 / 367Linearity 10 years
209 / 368Total Rank
344 / 368Dividend Rank
232 / 368Valuation Rank
140 / 368Piotroski Rank
331 / 368Muliplier Rank
175 / 368EBITDA - OVID ranking 141 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.